SciSparc
SPRC
4 hedge funds and large institutions have $129K invested in SciSparc in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
56% less capital invested
Capital invested by funds: $294K → $129K (-$164K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$24.5K |
| 2 |
SG
StoneX Group
New York
|
+$18.3K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$41K |
| 2 |
AC
Armistice Capital
New York
|
-$714 |
SPRC Hedge Fund Activity: Q3 2022 in Review
4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in SciSparc (SPRC) for Q3 2022, worth a combined $129K — down 56% from $294K a quarter earlier.
Fund positioning in SPRC was balanced in Q3 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $24.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $41K sold.
- 4 institutional investors held SciSparc (SPRC) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $129K of SciSparc stock for Q3 2022, down 56% quarter-over-quarter.
- 2 funds opened new SciSparc positions in Q3 2022 and 2 closed out, a net change of 0 holders.
- The largest SciSparc buyer in Q3 2022 was UBS Group, an estimated $24.5K added.
- The largest SciSparc seller in Q3 2022 was Citadel Advisors, an estimated $41K sold.
Based on aggregated 13F filings for Q3 2022.